Literature DB >> 28769230

THROMBOLYSIS IN MYOCARDIAL INFARCTION.

S D Karloopia1.   

Abstract

Entities:  

Keywords:  Myocardial infarction; Reperfusion; Thrombolysis therapeutic

Year:  2017        PMID: 28769230      PMCID: PMC5529795          DOI: 10.1016/S0377-1237(17)30908-5

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


× No keyword cloud information.
  20 in total

1.  Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen activator.

Authors:  W Weimar; J Stibbe; A J van Seyen; A Billiau; P De Somer; D Collen
Journal:  Lancet       Date:  1981-11-07       Impact factor: 79.321

Review 2.  Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis.

Authors:  C B Kim; E Braunwald
Journal:  Circulation       Date:  1993-11       Impact factor: 29.690

Review 3.  On the future of thrombolytic therapy for acute myocardial infarction.

Authors:  D Collen; H R Lijnen
Journal:  Am J Cardiol       Date:  1993-12-16       Impact factor: 2.778

4.  Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. EMERAS (Estudio Multicéntrico Estreptoquinasa Repúblicas de América del Sur) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1993-09-25       Impact factor: 79.321

Review 5.  Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina.

Authors:  M J Davies; A C Thomas
Journal:  Br Heart J       Date:  1985-04

6.  Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).

Authors: 
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

7.  Risk stratification and survival after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1983-08-11       Impact factor: 91.245

8.  Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.

Authors: 
Journal:  Circulation       Date:  1994-04       Impact factor: 29.690

9.  GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.

Authors: 
Journal:  Lancet       Date:  1990-07-14       Impact factor: 79.321

10.  Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction.

Authors:  M A DeWood; J Spores; R Notske; L T Mouser; R Burroughs; M S Golden; H T Lang
Journal:  N Engl J Med       Date:  1980-10-16       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.